Healthcare & Life Sciences
Convexia
United States
series-a
series-a
Stage
1
Investors
About
Convexia is an AI-driven pharmaceutical platform that uses autonomous software agents to identify overlooked preclinical drug candidates, run computational biology models to assess their safety and efficacy in silico, and simulate clinical trials and commercial outcomes to support advancement toward Phase 1 trials.
Explore Convexia's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.